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A B S T R A C T
Background
Slow-release fluoride devices have been investigated as a potentially cost-effective method of reducing dental caries in people with high
risk of disease. This is the second update of the Cochrane Review first published in 2006 and previously updated in 2014.
Objectives
To evaluate the effectiveness and safety of different types of slow-release fluoride devices on preventing, arresting, or reversing the
progression of carious lesions on all surface types of primary (deciduous) and permanent teeth.
Search methods
Cochrane Oral Health’s Information Specialist searched the following electronic databases: Cochrane Oral Health’s Trials Register (to
23 January 2018); the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 12) in the Cochrane Library (searched
23 January 2018); MEDLINE Ovid (1946 to 23 January 2018); and Embase Ovid (1980 to 23 January 2018). The US National
Institutes of HealthOngoing Trials Register ClinicalTrials.gov, and theWorldHealthOrganization International Clinical Trials Registry
Platform were searched for ongoing trials (23 January 2018). We placed no restrictions on the language or date of publication when
searching the electronic databases.
Selection criteria
Parallel randomised controlled trials (RCTs) comparing slow-release fluoride devices with an alternative fluoride treatment, placebo, or
no intervention in all age groups. The main outcome measures sought were changes in numbers of decayed, missing, and filled teeth
or surfaces (DMFT/DMFS in permanent teeth or dmft/dmfs in primary teeth), and progression of carious lesions through enamel and
into dentine.
Data collection and analysis
We conducted data collection and analysis using standard Cochrane review methods. At least two review authors independently
performed all the key steps in the review such as screening of abstracts, application of inclusion criteria, data extraction, and risk of bias
assessment. We resolved discrepancies through discussions or arbitration by a third or fourth review author.
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Main results
We found no evidence comparing slow-release fluoride devices against other types of fluoride therapy.
We found only one double-blind RCT involving 174 children comparing a slow-release fluoride device (glass beads with fluoride were
attached to buccal surfaces of right maxillary first permanent molar teeth) against control (glass beads without fluoride were attached
to buccal surfaces of right maxillary first permanent molar teeth). This study was assessed to be at high risk of bias. The study recruited
children from seven schools in an area of deprivation that had low levels of fluoride in the water. The mean age at the beginning of the
study was 8.8 years and at the termination was 10.9 years. DMFT in permanent teeth or dmft in primary teeth was greater than one
at the start of the study and greater than one million colony-forming units of Streptococcus mutans per millilitre of saliva.
Although 132 children were still included in the trial at the two-year completion point, examination and statistical analysis was
performed on only the 63 children (31 in intervention group, 32 in control group) who had retained the beads (retention rate was
47.7% at 2 years). Among these 63 children, caries increment was reported to be statistically significantly lower in the intervention
group than in the control group (DMFT: mean difference -0.72, 95% confidence interval (CI) -1.23 to -0.21; DMFS: mean difference
-1.52, 95% CI -2.68 to -0.36 (very low-quality evidence)). Although this difference was clinically significant, it only holds true for
those children who maintain the fluoride beads; over 50% of children did not retain the beads.
Harms were not reported within the trial report. Evidence for other outcomes sought in this review (progression to of caries lesion,
dental pain, healthcare utilisation data) were also not reported.
Authors’ conclusions
There is insufficient evidence to determine the caries-inhibiting effect of slow-release fluoride glass beads. The body of evidence available
is of very low quality and there is a potential overestimation of benefit to the average child. The applicability of the findings to the
wider population is unclear; the study had included children from a deprived area that had low levels of fluoride in drinking water, and
were considered at high risk of caries. In addition, the evidence was only obtained from children who still had the bead attached at 2
years (48% of all available children); children who had lost their slow-release fluoride devices earlier might not have benefited as much
from the devices.
P L A I N L A N G U A G E S U M M A R Y
Slow-release fluoride devices for the control of dental decay
Review question
We conducted this review to assess the effects of different types of slow-release fluoride devices on preventing, stopping, or reversing
the progression of tooth decay on all surface types of deciduous (’baby’) and permanent teeth.
Background
Tooth decay is not distributed evenly among the population, with certain groups being at greater risk of developing tooth decay than
others. For example, research in Scotland has shown that 50% of tooth decay occurs in 11% of 5-year-old children and only 6% of
14-year-old children. In light of this uneven distribution, it is often suggested that these small percentages of children may be offered
targeted-caries preventive measures to great potential effect, in a cost effective manner. One such preventive measure is the use of slow-
release fluoride devices (e.g. slow-dissolving fluoride-releasing glass beads).
Study characteristics
Authors from Cochrane Oral Health carried out this review of existing studies and the evidence is current up to 23 January 2018. We
searched scientific databases for clinical trials in children or adults treated with slow-release fluoride devices compared with another
type of fluoride treatment (e.g. toothpaste, mouthrinse, gel, or varnish), placebo (a pretend treatment), or no treatment (usual care).
Treatments had to be used and monitored for a minimum of 1 year.
Key results
We found one study that randomised 174 children to either slow-dissolving, fluoride-releasing glass beads or placebo beads. The setting
was an inner city school in an area served with low-fluoride water. Only 48% of children retained the beads and were available for
analysis.
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There is insufficient evidence to determine whether slow-release fluoride devices (such as glass beads) help reduce dental decay. Retention
of the beads is a problem.
Quality of the evidence
The evidence relating caries increment, side effects and retention was considered to be very low quality.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Slow- release fluoride devices compared with control for the control of dental decay
Patient or population: children with high risk of dental decay
Settings: low water f luoride level area, inner city school
Intervention: slow-release f luoride devices
Comparison: control
Outcomes Illustrative comparative risks∗ (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Slow- release fluoride
device
Increase in DMFT at
2 years compared with
baseline
(DMFT scale ranged
f rom 0 to 32)
The mean was 0.91 (SD
1.36)
The mean was
0.72 lower (95% CI -1.
23 to -0.21)
Not applicable 63 (1 study) ⊕©©©
very low1
-
Increase in DMFS at
2 years compared with
baseline
(DMFS scale ranged
f rom 0 to 128)
The mean was 1.81 (SD
3.28)
The mean was
1.52 lower (95% CI -2.
68 to -0.36)
Not applicable 63 (1 study) ⊕©©©
very low1
-
Progression of caries
lesion through enamel
or into dentine
- - - - - No evidence found
Dental pain due to de-
cay
- - - - No evidence found
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Harms of slow- release
fluoride devices
- - - 132 (1 study) ⊕©©©
very low1,2
Study reported that
no irritat ions or other
harms were reported
Participant satisfac-
tion
- - - - - No RCT evidence found
Retention of slow- re-
lease fluoride devices
- - - 132 (1 study) ⊕©©©
very low1
Only 63/ 132 (47.7%)
children who were st ill
available at 2-year fol-
low-up had the devices
intact
∗As there was only 1 included study, the mean values in the control group was used as the assumed risk. The corresponding risk (and its 95% conf idence interval) is based
on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; DMFT: decayed, missing, and f illed permanent teeth; DMFS: decayed, missing, and f illed permanent surfaces; RCT: randomised controlled trial; SD:
standard deviat ion.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
1Quality of the evidence was af fected by serious attrit ion bias (only 36%of part icipants randomised were included in analysis),
relat ively small overall sample size and evidence was only obtained f rom a specif ic group of part icipants (children with
high risk of caries, in an area with low levels of f luoride in tap water).
2Unclear how reports about harms were obtained. No suggest ions f rom the report that these were systematically checked.
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B A C K G R O U N D
Description of the condition
Dental decay is not distributed evenly among the population. For
example, in epidemiological surveys in Scotland, 50% of the dis-
ease can be accounted for by including only 11% of 5-year-old
children and only 6% of 14-year-old children (DHSRU 2003;
Pitts 1999). In light of this uneven distribution, it is often ad-
vocated that these small percentages of children may be offered
targeted caries preventive measures to great potential effect, in a
cost-effectivemanner. However, some dentists have cautioned that
such targeted interventions may fail to effect real change if they
require the targeted individuals to adopt different social norms
from their peers (Batchelor 2002).
Description of the intervention
Fluoride is valuable not only in the prevention of caries but also in
reversal and remineralisation of lesions (Biesbrock 1998). How-
ever, this would appear to be a slow process requiring the presence
of fluoride in themouth for extended periods of time (Rolla 1990),
and the low concentrations found after brushing with fluoride-
containing dentifrice may not be sufficient to reduce the dissolu-
tion of tooth mineral significantly (ten Cate 1999).
There are a number of methods of delivering supplemental fluo-
ride, including tablets, mouthrinses, fluoridated salt, toothpastes,
gels, and varnishes. Several of these have been the subject of
Cochrane Reviews (Marinho 2003; Marinho 2013; Marinho
2015; Marinho 2016; Walsh 2010). A number of devices have
been used to provide a slow-released, more sustained presence of
fluoride within the buccal cavity showing that it is possible to
sustain elevated levels of fluoride within saliva and plaque (Mirth
1982).
How the intervention might work
The desired properties of fluoride-releasing devices include being
safe to administer, providing low and continuous intraoral fluoride
concentration of at least 1 year, being quick and easy to adminis-
ter, being robust and being clinically effective (Toumba 2001). In
terms of the desired properties of fluoride-releasing devices, only
glass ionomer cements meet the criterion of long-term fluoride re-
lease of at least 1 year. Two types of intraoral fluoride slow-release
device are currently in use, the co-polymer membrane (Cowsar
1976), and slow-dissolving fluoride glass beads (Toumba 1993).
The glass beads, which are 4 mm in diameter, are attached to the
buccal aspect of molar teeth using an acid-etch composite. The
percentage of incorporated fluoride can be adjusted to vary the
amount released and the beads have been shown to lead to raised
salivary fluoride levels for up to 2 years (Toumba 1993).
Why it is important to do this review
Concerns that accidental swallowing of fluoride-containing de-
vices might lead to gastric irritation or adverse effects following
raised plasma fluoride concentrations were addressed in a study
reported in 1994 (Curzon 2004). Glass beads constituted with
13.3% fluoride were deliberately swallowed by five adult volun-
teers and their venous blood was subsequently drawn and analysed
at intervals. Plasma fluoride concentration did not rise from base-
line during 2 hours of monitoring in contrast to fluoride tablets,
which gave a detectable increase peaking after 20 to 30 minutes.
Based on this finding, the authors concluded that fluoride released
from slow-dissolving glass did not present a health risk.
The purpose of this reviewwas to determine, if possible, the clinical
effectiveness of slow-release fluoride devices for halting, or slowing,
the progression of enamel, dentine, and carious root lesions on
different tooth surfaces of primary (deciduous) and permanent
teeth. It is anticipated that if such slow-fluoride releasing devices
did prove to be clinically effective they would primarily be offered
to children regarded as being at high risk of developing dental
caries.
This is the second update of the Cochrane Review first published
in 2006 and previously updated in 2014 (Bonner 2005; Bonner
2006; Chong 2014).
O B J E C T I V E S
To evaluate the effectiveness and safety of different types of slow-
release fluoride devices on preventing, arresting, or reversing the
progression of carious lesions on all surface types of primary (de-
ciduous) and permanent teeth.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Parallel randomised controlled trials (RCTs) irrespective of pub-
lication status, language, or blinding. We did not include split-
mouth trials because the treatment applied to one half may have
contaminated the other half of the mouth.
Types of participants
Children or adults.
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Types of interventions
Intervention
• Slow-release fluoride devices. (We considered all types of
slow-release fluoride device. However, currently the only
substances that can release fluoride over a sufficient period are co-
polymer acrylic reservoir types and slow-dissolving glass beads.)
Comparison
One or more of the following:
1. alternative fluoride treatment:
◦ topical fluoride in the form of toothpaste, mouthrinse,
gel, or varnish at any dose, frequency, duration, or method of
administration and with any of the following active agents/
ingredients: sodium fluoride (NaF), sodium
monofluorophosphate (SMFP), stannous fluoride (SnF),
acidulated phosphate fluoride (APF), amine fluoride (amine F);
or
2. placebo; or
3. no intervention or ’usual care’.
We included only studies with a minimum intervention and fol-
low-up of 1 year.
Types of outcome measures
Primary outcomes
1. Changes in decayed, missing, and filled teeth, or surfaces,
or both (DMFT/DMFS in permanent teeth - dmft/dmfs in
primary teeth). We defined caries as being recorded at the
dentine level of diagnosis. If caries data only reported caries at
both dentine and enamel lesions combined then we used this in
the analysis (see below for more information).
2. Progression of caries lesion through enamel or into dentine.
Secondary outcomes
1. Dental pain due to decay.
2. Retention of slow-release fluoride devices.
3. Harms of slow-release fluoride devices.
4. Participant satisfaction as measured by validated participant
satisfaction questionnaires.
5. Use of healthcare resources, such as cost effectiveness of
slow-release fluoride devices, time taken to fit slow-release
fluoride devices, and number of visits to the dentist for attention
or re-fitting of slow-release fluoride devices.
Outcomes may have been assessed at more than one period of
follow-up. If data from multiple time points were available, we
analysed them as separate analyses at the 3 years’ time point (short-
term data, including studies reporting 2 to 3 years of follow-up),
medium-term data (including studies with 4 to 6 years of follow-
up), or long-term data (at least 7 years of follow-up).
We focused on shorter-term data, as longer-term data may be
useful but may lose its reliability due to dropouts following natural
loss of primary teeth in the case of children.
Different ways of assessing/reporting caries increment (change
from baseline as measured by the decayed-missing-filled (DMF)
index) in the trials were recorded separately and/or combined ac-
cording to the components of the index chosen and units mea-
sured (DMFT/S, or DFT/S, or DT/S, or FT/S); types of tooth/
surface considered (primary/permanent teeth/surfaces, first molar
teeth, approximal surfaces, etc.); state of tooth eruption consid-
ered (erupted and/or erupting teeth or surface); diagnostic thresh-
olds used (cavitated/dentine lesions, non-cavitated/incipient le-
sions);methods of examination adopted (clinical or radiographical
or both, other); and approaches to account or not for reversals in
caries increment adopted (in a net or observed caries increment re-
spectively). In addition, caries increment data have been recorded
at all reported time periods (at various follow-ups).
As we were aware that caries increment could be reported dif-
ferently in different trials, we developed a set of a priori rules to
choose the primary outcome data (D(M)FS) for analysis from each
study: DFS data would be chosen over DMFS data, and these
would be chosen over DS or FS; data for ’all surface types com-
bined’ would be chosen over data for ’specific types’ only; data
for ’all erupted and erupting teeth combined’ would be chosen
over data for ’erupted’ only, and these over data for ’erupting’
only; data from ’clinical and radiological examinations combined’
would be chosen over data from ’clinical’ only, and these over ’ra-
diological’ only; data for dentinal/cavitated caries lesions would
be chosen over data for enamel/non-cavitated lesions; net caries
increment data would be chosen over crude (observed) increment
data; and follow-up nearest to 3 years (often the one at the end
of the treatment period) would be chosen over all other lengths
of follow-up, unless otherwise stated. When no specification was
provided with regard to the methods of examination adopted, di-
agnostic thresholds used, groups of teeth and types of tooth erup-
tion recorded, and approaches for reversals adopted, the primary
choices described above were assumed.
Search methods for identification of studies
Electronic searches
Cochrane Oral Health’s Information Specialist conducted system-
atic searches in the following databases for randomised controlled
trials and controlled clinical trials. There were no language, pub-
lication year or publication status restrictions:
• Cochrane Oral Health’s Trials Register (to 23 January 2018)
(Appendix 1);
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• Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 12) in the Cochrane Library (searched
23 January 2018) (Appendix 2);
• MEDLINE Ovid (1946 to 23 January 2018) (Appendix 3);
• Embase Ovid (1980 to 23 January 2018) (Appendix 4).
Subject strategiesweremodelled on the search strategy designed for
MEDLINE Ovid. Where appropriate, they were combined with
subject strategy adaptations of the highly sensitive search strategy
designed by Cochrane for identifying randomised controlled trials
and controlled clinical trials as described in theCochrane Handbook
for Systematic Reviews of Interventions Chapter 6 (Lefebvre 2011).
Searching other resources
We handsearched all the references lists of the included studies to
identify any additional studies.
We searched the following databases for ongoing trials (Appendix
5 for search strategies applied):
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (clinicaltrials.gov) (to 23 January 2018);
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch/) (to 23 January
2018).
Data collection and analysis
We used Review Manager 5 to perform every step of the review
(Review Manager 2014). We assessed the risk of bias of the in-
cluded studies according to the criteria described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Selection of studies
Two review authors independently assessed the titles and abstracts
of all reports identified by the online searches on the basis of title,
keywords, and abstract (when this was available) to determine if
the study was likely to be relevant.We obtained the full-text report
of all potentially relevant articles.
The review authors were not blinded with respect to report au-
thors, journals, date of publication, sources of financial support,
or results. Two review authors independently applied the inclu-
sion criteria in duplicate, and compared opinions afterwards in
discussion with a third review author.
Data extraction and management
We used an itemised form to ensure consistency of data extraction
between studies and between assessors. At least two review authors
independently carried out the data extraction, and, in case of dis-
crepancies, we sought consensus by discussion with a third review
author.
Assessment of risk of bias in included studies
At least two review authors undertook the risk of bias assessment
of included trials. We resolved any disagreements by discussion
with a third review author (Jan Clarkson).
Risk of bias assessment was conducted using the standard recom-
mended approach for assessing the risk of bias in studies included
in Cochrane Reviews (Higgins 2011), and assessed the following
domains:
• sequence generation;
• allocation concealment;
• blinding of participants and personnel;
• blinding of outcomes assessment;
• incomplete outcome data;
• selective outcome reporting;
• other bias.
The review authors would assign judgement on the risk of bias
for each domain into either one of these categories: high, low, or
unclear risk of bias. We based these assessments on the criteria
for making judgement listed in the Section 8.5 of the Cochrane
Handbook for Systematic Reviews of Interventions, which focuses on
whether the risk is of importance (i.e. whether the presence of the
risk could have an important impact the results or the conclusion
of the trial) rather than whether a risk bias was present or not
(Higgins 2011).
We categorised the overall risk of bias of individual studies. Stud-
ies were categorised as being at low, high, or unclear risk of bias
according to the following criteria:
• low risk of bias (plausible bias unlikely to seriously alter the
results) if all domains were at low risk of bias;
• high risk of bias (plausible bias that seriously weakens
confidence in the results) if one or more domains were at high
risk of bias; or
• unclear risk of bias (plausible bias that raises some doubt
about the results) if one or more domains were at unclear risk of
bias.
We also presented the ’Risk of bias’ summary graphically.
Measures of treatment effect
For dichotomous outcomes (where the outcome of interest was
either present or absent), the estimate of treatment effect of an
interventionwould have been expressed as risk ratios (RR) together
with 95% confidence intervals (CIs) or as hazard ratios if these
were available as time-to-event data. For continuous outcomes
(such as mean visual analogue scale (VAS) scores), we reported
mean differences (MD) and standard deviation (SD).
Unit of analysis issues
For cluster-randomised trials, we estimated the design effect using
the appropriate methods as detailed in Chapter 16 of theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
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Dealing with missing data
Where data were missing from the published report of a trial, we
attempted to contact the author(s) to obtain the data and clarify
any uncertainty. We based the review on an available-case analy-
sis basis where data were missing, followed by sensitivity analysis
where possible if the missing data posed a high risk of bias. For
continuous data, we used methods for estimating missing SDs in
Section 7.7.3 of the Cochrane Handbook for Systematic Reviews of
Interventions if appropriate (Higgins 2011). Otherwise, we would
not have undertaken any imputations or use any statistical meth-
ods to impute missing data.
Assessment of heterogeneity
We assessed clinical heterogeneity by examining the types of par-
ticipants (e.g. age), interventions (e.g. method of restoration), and
outcomes (e.g. pain relief ) in each study.
We assessed heterogeneity by inspection of the point estimates
and CIs on the forest plots. We assessed the variation in treatment
effects by means of Cochran’s test for heterogeneity and quantified
it using the I2 statistic. We considered heterogeneity statistically
significant if P value was < 0.1.
An approximate guide to interpretation provided in the Cochrane
Handbook for Systematic Reviews of Interventions is as follows (
Higgins 2011):
• 0% to 40%: might not be important;
• 30% to 60%: may represent moderate heterogeneity;
• 50% to 90%: may represent substantial heterogeneity;
• 75% to 100%: considerable heterogeneity.
The importance of the observed value of the I2 statistic depends on
1) the magnitude and direction of the effects and 2) the strength
of evidence for heterogeneity (e.g. P value from the Chi2 test or a
CI for the I2 statistic).
Assessment of reporting biases
Reporting bias could be assessed as between-study publication or
within-study reporting bias.
If there had been sufficient numbers of trials (more than 10) in any
meta-analysis, we would have assessed publication bias according
to the recommendations on testing for funnel plot asymmetry (
Egger 1997) as described in Section10.4 of theCochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). If we had
identified asymmetry, we would have examined possible causes.
Alternatively, we would have assessed this using a table to list the
outcomes reported by each study included to review, to identify
whether there were any studies that did not report outcomes that
had been reported by most studies.
We would have assessed within-study reporting bias by comparing
the outcomes reported in the published report against the out-
comes reported in the study protocol, whenever this could be ob-
tained. If not, then outcomes listed in the methods section could
be compared with those whose results were reported. If non-sig-
nificant results were mentioned but were not reported adequately,
bias in a meta-analysis is likely to occur and we would have sought
further information from authors of the study reports. Otherwise,
we would note this as ’high’ risk of bias. If there was insufficient
information to judge the risk of bias, we would have noted it as
’unclear’ risk of bias.
Data synthesis
For data analysis, we were guided by the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). For the con-
tinuous outcome measures analysed in this review, we used means
and SDs to summarise the data for each group. We would have
used standardised mean difference (SMD) as a summary statistic
in meta-analysis when the studies all assessed the same outcome
but measured it in a variety of ways.
For dichotomous data, the estimate of effect of an intervention
would have been expressed as RRs, together with 95% CIs or as
hazard ratios if these were reported as time-to-event data.
We would have used a random-effects model to pool effect esti-
mates provided it was appropriate to pool the data (as assessed by
clinical and statistical heterogeneity).
Subgroup analysis and investigation of heterogeneity
Where data were available, we would have conducted subgroup
analyses to investigate the effects of the following factors: different
tooth surfaces (enamel, dentine, and root surface), amount of flu-
oride released and duration of exposure, adults/children, or length
of follow-up.
Sensitivity analysis
We conducted sensitivity analysis based on risk of bias where ap-
plicable.
Presentation of main results
We developed a ’Summary of findings’ table for each compari-
son and for the main outcomes of this review following GRADE
methods (GRADE 2004). The quality of the body of evidence was
assessed with reference to the overall risk of bias of the included
study, the directness of the evidence, the inconsistency of the re-
sults, the precision of the estimates, and the risk of publication
bias. We categorised the quality of the body of evidence of each of
the main outcomes as high, moderate, low or very low.
R E S U L T S
Description of studies
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Results of the search
Initial searches of all sources yielded 73 titles and abstracts, we
found an additional 324 records in the 2014 update, and 29 in this
latest update. In total, 426 records have been assessed for eligibility.
We obtained the full texts of seven papers as being potentially
relevant to this review. Two of the seven papers described the same
study, which met the inclusion criteria for the review (Toumba
2005).We excluded the remainingfive studies andprovided details
in the Characteristics of excluded studies table. See Figure 1.
Figure 1. Study flow diagram.
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Included studies
Summary details are provided in the Characteristics of included
studies table. Only one study met the inclusion criteria of the
review (Toumba 2005).
Participants and setting
Toumba 2005 was conducted exclusively in an area of deprivation
in an inner-city area of Leeds, UK (postcode LS11). All exam-
inations and placement of devices were by one investigator and
utilised portable dental equipment set up in seven primary schools
in Beeston, Leeds.
Children had a mean age of 8.8 years at the beginning of the
study and 10.9 years at the termination. Number of DMFT in
permanent teeth or dmft in primary teeth were greater than one
at the start of the study and there were greater than one million
colony-formingunits of Streptococcus mutanspermillilitre of saliva.
Intervention
Glass beads were attached to buccal surfaces of right maxillary
first permanent molar teeth. In the intervention group, glass beads
were constituted with fluoride that was designed to be released
slowly as the glass dissolved in the mouth.
Control
Glass beads were manufactured without fluoride and attached to
buccal surfaces of right maxillary first permanent molar teeth.
Outcomes
Only one of the outcomes of interest to this review was reported in
this study; changes in decayed-missing-filled dmf (DMF). Com-
parisons were made between scores for DMF/dmf teeth and sur-
faces (dmft/dmfs in primary teeth, DMFT/DMFS in permanent
teeth) in intervention and control groups at baseline, mid-study,
and at termination (2 years). At the end of the study period, caries
increments were compared separately and combined for DMF/
dmf and DMFS/dmfs, and also specifically on occlusal surfaces.
Excluded studies
A summary is provided in the Characteristics of excluded studies
table.
We excluded five potentially relevant studies on the grounds of not
being randomised controlled trials (Aaltonen 2000; De Los Santos
1994), inadequate randomisation (Marini 1999; Trimpeneers
1996), being a split-mouth study (Trimpeneers 1996), or inap-
propriate intervention (Cagetti 2014).
Risk of bias in included studies
We assessed the included study as at high risk of bias. See Figure
2.
11Slow-release fluoride devices for the control of dental decay (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
The methods of randomisation and concealment of allocation
were clearly explained and were adequate to guard against bias.
Blinding
The control group participants were fitted with glass beads of
identical appearance to those fitted to the intervention arm, with
similar proportions of dislodgement. We also have been assured
that the examiner remained blinded to the study group until the
final examinations had been carried out.
Incomplete outcome data
Of concern was the high level of attrition in participant number.
The acknowledged number of dropouts was amodest 15; however,
only 63 of the original 174 children were included in the final
analysis. Children whose beads had dislodged were not assessed
for dental disease within the study. The total loss to follow-up was
thus 64%. Although the control (32 children) and intervention
(31 children) groups held similar numbers at the end of study
assessment, the review authors considered that the validity of an
extrapolation, from this trial to any potential use of this technique
in the prevention of caries in practice, requires analysis to be based
on all participants. Therefore, we consider that there is a high risk
of bias.
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Selective reporting
The protocol stated that outcomes weremeasured at 6months, 12
months, and 2 years, but only data for 2 years among participants
who still had the slow-release fluoride devices intact were reported.
Other potential sources of bias
We identified no other potential sources of bias.
Effects of interventions
See: Summary of findings for themain comparison Slow-release
fluoride devices compared with control for the control of dental
decay
Comparison of slow-release fluoride device versus
placebo or usual care
Number of decayed, missing, and filled teeth, or surfaces
(DMFT/S), or both
One hundred and thirty-two out of 174 children recruited to the
study were still included at 2 years, but only 63 children still had
beads attached. Those 63 children alone were included in the
comparisons (31 intervention and 32 control).
Caries increment was significantly lower in the intervention group
than in the control group (mean difference (MD) -0.72 DMFT,
95% confidence interval (CI) -1.23 to -0.21; MD -1.52 DMFS,
95% CI -2.68 to -0.36).
Clinical assessment of dmft and dmfs was also reported in this
study (Toumba 2005). However, we did not consider the data to
be usable as it was unclear how the quoted mean caries increment
for dmft/dmfs over the 2 years related to the values given at the
three time points and the study authors were unable to provide
clarification. In addition, we could not obtain information regard-
ing caries experience of the 52% of participants not included in
the analysis.
Progression of caries lesion through enamel or into dentine
The study reported no data on progression of caries lesion through
enamel or into dentine.
Dental pain
The study reported no data on dental pain.
Harms of slow-release fluoride devices
Harms were not measured or formally reported within the trial
report.
The study stated that “Despite this loss the devices were well tol-
erated by the children and there were no reports of irritation etc”.
Participant satisfaction
The study reported no data on participant satisfaction.
Retention of slow-release fluoride devices
Out of 174 children recruited into the trial, only 132 completed
the study. Of these, 31 in the intervention group and 32 in the
control group still had the devices intact, with an overall 63/132
(47.8%) retention of devices after 2 years. The devices used for
both groups appeared to be the same, except that the devices in
the intervention group contained fluoride.
Use of healthcare resources (e.g. cost effectiveness, time
taken to fit, number of visits to the dentist for attention, or
re-fitting of slow-release fluoride devices)
The study reported no data on use of healthcare resources.
Comparison of slow-release fluoride device versus
alternative fluoride therapy
We found no studies comparing a slow-release fluoride device ver-
sus alternative fluoride therapy.
D I S C U S S I O N
Summary of main results
Evidence from one small randomised controlled trial among pri-
mary school children in an area with low fluoride levels in drink-
ing water suggested that slow-release fluoride may reduce the in-
cidence of caries. However, this could be an overestimation, as the
results only reported the outcomes among children who retained
the devices at 2-year follow-up. The devices were intact in less than
half (47.7%) of all participants followed up at 2 years.
Overall completeness and applicability of
evidence
Although several slow-release fluoride devices have been devised,
the lack of well-controlled studies into the effectiveness of these is
disappointing.
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The study accepted for this review provided some evidence for
a reduction in dental disease progression in high-risk children.
Although relatively long-term evidence at 2 years was available,
this was obtained from a relatively small trial and data were only
obtained from 36% of the randomised children (63 children out
of 174 randomised). The exclusion of the majority of children
from the statistical analysis posed a significant risk of attrition bias,
as the effectiveness of caries prevention may have been lessened in
the children who lost the devices at an earlier date (Newell 1992).
This trial also randomised a specific population of participants;
that is, children attending schools in the inner city of Leeds, UK
(disadvantaged backgrounds).
Only two outcomes of interest were reported; DMFT/DMFS and
retention of slow-release fluoride devices at the end of 2 years, with
no data reported about other aspects of potential benefit, harms,
participant satisfaction, and cost effectiveness of the intervention.
Participant harm was not measured or discussed within the trial
report, resulting in an incomplete measure of potential of harms
and benefits from the devices (Toumba 2005).
Quality of the evidence
We graded the quality of the evidence obtained as very low using
GRADE. Our confidence in the evidence was affected by serious
study limitations (high risk of bias from attrition/selective report-
ing), potential limitations in applicability of the results to thewider
population, and an overall small number of participants included.
Furthermore, there was lack of completeness in the overview of
balance of benefits and harms data as potential adverse effects were
not reported.
Potential biases in the review process
Wehave not identified any potential biases in the review process, as
all data extractions and study inclusion/exclusion were conducted
as planned.
Agreements and disagreements with other
studies or reviews
The included study did not measure or reported any harms from
the devices.
Slow-dissolving glass beads similar to those used in the included
study are used commercially to deliver mineral supplements in
livestock. Since the adaptation of these devices for dental purpose
in humans, the same study authors have tested, in a limitedway, the
potential effect of swallowing fluoride-containing slow-dissolving
beads on enteric absorption of fluoride (Curzon 2004). Plasma
fluoride concentration did not rise from baseline during 2 hours of
monitoring in contrast to fluoride tablets, which gave a detectable
increase peaking after 20 minutes to 30 minutes. From this result,
they concluded that fluoride released from slow-dissolving glass
does not present a health risk.
The included study involved a limited number of children from
a defined high-risk population and points the way towards the
need for a larger, more general, trial. The question of retention
of the devices in place also needs to be addressed. For orthodon-
tic brackets, overall bonding failure rate was found to be 8% but
three times greater in children under the age of 12 years (Millett
1994). The discussion section of the included study report indi-
cated there was a particular problem with children deliberately
setting out to dislodge their bonded glass beads, but that improve-
ments in bonding techniques are already being explored (Toumba
2005). These include the factoring of a retention groove around
the periphery of the bead, which, it is claimed, improves retention
(Welbury 2003).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We conclude that there is only limited and very low-quality evi-
dence that provides insufficient information to determine whether
slow-release fluoride devices in the mouth may provide a measure
of protection against dental disease progression (Toumba 2005).
The quality of the evidence was very low because of a high pro-
portion of children not included in the study’s final analysis and
serious uncertainty applicability of study findings to the general
practice. The generalisability of these findings to routine dental
practice was questioned by the difficulties of retention of the de-
vices by the study population (children at high risk of caries, living
in an area with low levels of fluoride in tap water). Clearly, once the
beads have been dislodged they are no longer useful. In addition,
the beneficial effects seen might prescribe careful selection of the
target recipients to be cost-effective.
Implications for research
• Evidence: the study identified for this review did not
provide reliable evidence to answer the main question of the
review. Some limited evidence was found but weaknesses in this
were evident. To remedy these weaknesses, much larger, well-
conducted trials (randomised controlled trials, and where
possible, double-blinded) should be carried out. These trials
should, perhaps, draw comparisons between available alternatives
such as gels or varnishes and should provide analysis of results on
the basis of intention-to-treat and consider costs and benefits.
One of the authors of the included study has previously
concluded that the use of slow fluoride-releasing glass beads is a
cost-effective technique (Toumba 1997). The included study
focused on children from a low socio-economic area (Toumba
2005). It may also be of benefit to establish how much fluoride
should be released from the devices for optimum effect. Different
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materials and methods used for bonding may influence the
efficacy of fluoride release as well as the strength of the bonding.
• Population: participants from different risk categories.
• Intervention: slow-release fluoride devices, of different
materials or methods for bonding.
• Comparison: placebo or other slow-release fluoride devices
of a different material or methods of bonding, or amount of
fluoride released.
• Outcomes:
◦ primary outcomes:
a) number of decayed, missing, and filled teeth or
surfaces or both (DMFT/DMFS in permanent teeth - dmft/
dmfs in primary teeth);
b) progression of caries lesion through enamel or
into dentine;
◦ secondary outcomes:
a) dental pain;
b) harms of slow-release fluoride devices, including
adverse effects of swallowing dislodged devices;
c) participant satisfaction;
d) retention of devices (number of devices staying
intact);
e) other healthcare utilisation data (e.g. time taken
to fit, number of visits to the dentist for attention to or re-fitting
of slow-release fluoride devices and cost effectiveness of the slow-
release fluoride devices).
• Time: the intervention and follow-up should be conducted
for a minimum of 1 year, and preferable for a longer duration.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Toumba 2005
Methods Double-blind RCT, 2-year follow-up
Participants Sample: 174 children, mean age 8.8 years
Dropouts: 132 children were still in the trial at the 2-year completion point; however,
only 63 had retained the fitted glass beads. The baseline characteristics and outcomes
data were only reported for 63 children, 31 in intervention group and 32 in control
group, who had retained the fitted glass beads to the study end point
Inclusion criteria:
• attended 1 of 7 schools, residing in postcode LS11 (inner city, Leeds, UK)
• aged 8 years old (born in 1983)
• dmft or DMFT > 1 and > 1 million Streptococcus mutans (colony-forming units)/
mL saliva
• no medical contraindications
Interventions Intervention:
• glass beads constituted with fluoride that was designed to be released slowly as the
glass dissolved in the mouth
Control:
• glass beads manufactured without fluoride with identical appearance to the
intervention
Method of fitting (all participants):
• glass beads were attached to buccal surfaces of right maxillary first permanent
molar tooth. The tooth surface was cleaned with fluoride-free paste (washed and dried)
, the cleaned surface etched with 40% phosphoric acid gel (washed and dried), and
Scotchbond, light-cure bonding agent was applied thinly to both tooth surface and
bead. The glass device was then attached to the tooth using Herculite, universal shade,
light-curing composite resin
• 1 spare device was provided in each container and replacement was permitted, in
the case of dislodgment, for up to 4 months from the start of the study
• examinations and device fitment was carried out on school premises using
portable dental equipment
Outcomes • Dental caries were assessed at baseline, 1 year, and 2 years
• Gingival health was measured as periodontal health, cleanliness, and presence of
calculus
Outcomes reported (only for the children who completed the 2-year study with the
devices still intact)
• Streptococcus mutans counts were determined at baseline, 1 year, and 2 years
• Unstimulated whole mixed saliva, taken 2 hours postprandial, was collected at the
time of dental examination and analysed for fluoride concentration at baseline, 1 year,
and 2 years
• DMFT/dmft
• DMFS/dmfs
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Toumba 2005 (Continued)
Source of Funding The trial was supported by a grant from the Wolfston Foundation
Declaration of Interest None declared
Notes Study area was 1 of social deprivation and low level of dental care. The tap water in area
had less than 0.1 mg/L of fluoride and dental caries were among the highest in the UK
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number tables were used to generate
sequence
Allocation concealment (selection bias) Low risk Glass beads were in containers in plastic bags
coded by a third party and numbered using the
random number table. Codes were kept in a safe
until end of study
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “Because both the control and test glass pel-
lets were identical in shape and appearance the
examiner could not know which device was in
place in each child’s mouth. The glass devices
were coded by an independent investigator not
involved in the clinical trial to avoid any bias.
The glass samples for the devices were supplied
by the manufacturer and were of two types, the
test and control glass devices. The control glass
device contained no F [fluoride] at all, but was
identical in every other aspect including appear-
ance”
Participants in control and intervention groups
were fitted with glass bead devices of identi-
cal appearance. Glass beads were in containers
coded by a third party (using a random num-
bers table) and neither the investigator nor the
participants were aware of which type was fitted
to each individual
All examinations and device placement was by 1
investigator who demonstrated his reliability of
assessments (Kappa 0.86 for caries and 0.76 for
periodontal indices) on a group of 25 children
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Likely to be low risk; identical appearance of
beads
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Toumba 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcome was only available for 63 out of 174
children randomised (36%). Only childrenwho
retained the beads were included in the analysis
Selective reporting (reporting bias) High risk Only data for children who retained the beads
were reported for both baseline data and also
outcome at 2 years. Outcomes were measured
at 6 and 12 months but not reported
Other bias Low risk We identified no other potential sources of bias.
dmfs: decayed, missing, and filled primary surfaces; DMFS: decayed, missing, and filled permanent surfaces; dmft: decayed, missing,
and filled primary teeth; DMFT: decayed, missing, and filled permanent teeth; RCT: randomised controlled trial.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aaltonen 2000 Not an RCT. A cohort study. Participants assigned to groups based on their risk level and “regions of prede-
termined dental health clinic”
Cagetti 2014 Inappropriate intervention
De Los Santos 1994 Not an RCT. It was a short duration study involving 6 participants fitted with prepared third-molar extracts
restrained by using acrylic holders
Marini 1999 The article had stated that “the patients were randomly divided into two groups”. However, information from
contact with study author suggested that there was no randomisation procedure - this was not an RCT
Trimpeneers 1996 A split-mouth study. All participants received both treatments at the same time
RCT: randomised controlled trial.
20Slow-release fluoride devices for the control of dental decay (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Slow-release fluoride device versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change of caries (increase in
decayed, missing, and filled
permanent teeth (DMFT)) at 2
years compared to baseline
1 63 Mean Difference (IV, Fixed, 95% CI) -0.72 [-1.23, -0.21]
2 Change of caries (increase in
decayed, missing, and filled
permanent surfaces (DMFS))
at 2 years compared to baseline
1 63 Mean Difference (IV, Fixed, 95% CI) -1.52 [-2.68, -0.36]
Analysis 1.1. Comparison 1 Slow-release fluoride device versus control, Outcome 1 Change of caries
(increase in decayed, missing, and filled permanent teeth (DMFT)) at 2 years compared to baseline.
Review: Slow-release fluoride devices for the control of dental decay
Comparison: 1 Slow-release fluoride device versus control
Outcome: 1 Change of caries (increase in decayed, missing, and filled permanent teeth (DMFT)) at 2 years compared to baseline
Study or subgroup Slow-release fluoride Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Toumba 2005 31 0.19 (0.56) 32 0.91 (1.36) 100.0 % -0.72 [ -1.23, -0.21 ]
Total (95% CI) 31 32 100.0 % -0.72 [ -1.23, -0.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.76 (P = 0.0057)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours fluoride Favours control
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Analysis 1.2. Comparison 1 Slow-release fluoride device versus control, Outcome 2 Change of caries
(increase in decayed, missing, and filled permanent surfaces (DMFS)) at 2 years compared to baseline.
Review: Slow-release fluoride devices for the control of dental decay
Comparison: 1 Slow-release fluoride device versus control
Outcome: 2 Change of caries (increase in decayed, missing, and filled permanent surfaces (DMFS)) at 2 years compared to baseline
Study or subgroup Slow-release fluoride Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Toumba 2005 31 0.29 (0.72) 32 1.81 (3.28) 100.0 % -1.52 [ -2.68, -0.36 ]
Total (95% CI) 31 32 100.0 % -1.52 [ -2.68, -0.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.56 (P = 0.011)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours fluoride Favours control
A P P E N D I C E S
Appendix 1. Cochrane Oral Health’s Trials Register search strategy
#1 (teeth and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#2 (tooth and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#3 (dental and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#4 (enamel and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#5 (dentin and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#6 (root* and (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*)) [REFERENCE] [STANDARD]
#7 #1 or #2 or #3 or #4 or #5 or #6 [REFERENCE] [STANDARD]
#8 fluorid* [REFERENCE] [STANDARD]
#9 (slow* and (releas* or action*)) [REFERENCE] [STANDARD]
#10 ((delay* or prolong* or control* or sustain* or timed*) and (releas* or action*)) [REFERENCE] [STANDARD]
#11 (glass and (bead* or devic*)) [REFERENCE] [STANDARD]
#12 (“copolymer acrylic reservoir” or “membrane controlled reservoir” or “copolymer membrane” or “hydroxyapatite Eudraglit”)
[REFERENCE] [STANDARD]
#13 #9 or #10 or #11 or #12 [REFERENCE] [STANDARD]
#14 #7 and #8 and #13 [REFERENCE] [STANDARD]
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Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
#1 [mh “Tooth demineralization”]
#2 (teeth near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#3 (tooth near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#4 (dental near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#5 (enamel near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#6 (dentin near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#7 (root* near/5 (cavit* or caries or carious or decay* or lesion* or deminerali* or reminerali*))
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7
#9 [mh Fluorides]
#10 fluorid*
#11 #9 or #10
#12 [mh ˆ“Delayed action preparations”]
#13 (slow* near/5 (action* or releas*))
#14 ((delay* or prolong* or control* or sustain* or timed*) near/5 (releas* or action*))
#15 (“copolymer acrylic reservoir” or “membrane controlled reservoir” or “copolymer membrane” or “hyroxyapatite Eudraglit”)
#16 #12 or #13 or #14 or #15
#17 #8 and #11 and #16
Appendix 3. MEDLINE (Ovid) search strategy
1. exp Tooth demineralization/
2. (teeth adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
3. (tooth adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
4. (dental adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
5. (enamel adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
6. (dentin adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
7. (root adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
8. or/1-7
9. exp Fluorides/
10. fluorid$.mp.
11. 9 or 10
12. Delayed action preparations/
13. (slow$ adj5 (releas$ or action$)).mp.
14. ((delay$ or prolong$ or control$ or sustain$ or timed$) adj5 (releas$ or action$)).mp.
15. (glass adj3 (bead$ or devic$)).mp.
16. (“copolymer acrylic reservoir” or “membrane controlled reservoir” or “copolymer membrane” or “hydroxyapatite Eudraglit”).mp.
17. or/12-16
18. 8 and 11 and 17
Appendix 4. Embase (Ovid) search strategy
1. Dental caries/
2. (teeth adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
3. (tooth adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
4. (dental adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
5. (enamel adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
6. (dentin adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
7. (root adj5 (cavit$ or caries or carious or decay$ or lesion$ or deminerali$ or reminerali$)).mp.
8. or/1-7
9. Fluoride/
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10. fluorid$.mp.
11. 9 or 10
12. Delayed release formulations/
13. (slow$ adj5 (releas$ or action$)).mp.
14. ((delay$ or prolong$ or control$ or sustain$ or timed$) adj5 (releas$ or action$)).mp.
15. (glass adj3 (bead$ or devic$)).mp.
16. (“copolymer acrylic reservoir” or “membrane controlled reservoir” or “copolymer membrane” or “hydroxyapatite Eudraglit”).mp.
17. or/12-16
18. 8 and 11 and 17
Appendix 5. US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and World
Health Organization International Clinical Trials Registry Platform search strategy
caries and fluoride and slow release
caries and fluoride and delayed release
caries and fluoride and controlled release
caries and fluoride and sustained release
WH A T ’ S N E W
Last assessed as up-to-date: 23 January 2018.
Date Event Description
23 January 2018 New citation required but conclusions have not changed Searches updated, no new studies for inclusion, conclu-
sions remain the same. Minor edits
23 January 2018 New search has been performed Searches updated 23 January 2018. We did not find any
new studies for inclusion
H I S T O R Y
Protocol first published: Issue 1, 2005
Review first published: Issue 4, 2006
Date Event Description
18 April 2016 Amended Minor amendment.
13 August 2014 New search has been performed Searches updated 13 August 2014. We did not find any
new studies for inclusion
13 August 2014 New citation required but conclusions have not changed Methods updated and changes to authorship and the
format of the review, including edits to the outcomes
list to reflect the key patient outcomes required for the
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(Continued)
’Summary of findings’ table.
Clarified intentions of inclusion/exclusion criteria. Re-
moved ’quasi-randomised’ trials, stated inclusion of
non-blinded studies and exclusion of cross-over trials.
Only includes trials with treatment and follow-up of at
least 1 year
1 August 2008 Amended Converted to new review format.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the 2014 update, the methods section was edited to add clarity to the inclusion criteria and data analysis plans. The most important
change was the addition of aminimum duration of study or intervention (1 year).We removed ’quasi-randomised’ trials, stated inclusion
of non-blinded studies and exclusion of cross-over trials.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cariostatic Agents [∗administration & dosage]; DMF Index; Delayed-Action Preparations [administration & dosage]; Dental Caries
[∗prevention & control]; Fluorides [∗administration & dosage]; Glass; Randomized Controlled Trials as Topic
MeSH check words
Child; Humans
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